Health In Tech (HIT) Stock Price

Health In Tech Price

NYSE·CLOSED
1.06USD-0.03 (-2.79 %)
Market closed

Over the last 2 years Health In Tech grew revenue by 83.8% annually, reaching 19.49 M USD. Earnings per share have grown at 191.1% per year over the last 2 years. For Health In Tech, the net margin of 3.4% is up versus 1.4% a few years ago. The consensus 12-month price target for Health In Tech is 4.59 USD, about 333.0% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 22% above its 52-week low.

Health In Tech stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Health In Tech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Health In Tech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Health In Tech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Health In Tech Stock Price History
DateHealth In Tech Price
7/10/20261.06 USD
7/9/20261.09 USD
7/8/20261.04 USD
7/7/20261.04 USD
7/6/20261.01 USD
7/2/20261.01 USD
7/1/20261.06 USD
6/30/20261.01 USD
6/29/20261.01 USD
6/26/20261.04 USD
6/25/20260.97 USD
6/24/20260.99 USD
6/23/20261.00 USD
6/22/20261.02 USD
6/18/20261.08 USD
6/17/20261.06 USD
6/16/20261.07 USD
6/15/20261.05 USD
6/12/20261.07 USD
6/11/20261.06 USD
6/10/20261.08 USD
6/9/20261.05 USD
6/8/20261.00 USD
6/5/20260.99 USD
6/4/20261.00 USD
6/3/20260.96 USD
6/2/20261.07 USD
6/1/20261.03 USD
5/29/20260.99 USD
5/28/20260.98 USD
5/27/20260.94 USD
5/26/20260.87 USD
5/22/20260.90 USD
5/21/20260.92 USD
5/20/20261.01 USD
5/19/20261.01 USD
5/18/20261.05 USD
5/15/20261.06 USD
5/14/20261.25 USD
5/13/20261.54 USD
5/12/20261.52 USD
5/11/20261.48 USD
5/8/20261.56 USD
5/7/20261.57 USD
5/6/20261.52 USD
5/5/20261.54 USD
5/4/20261.52 USD
5/1/20261.55 USD
4/30/20261.45 USD
4/29/20261.45 USD
4/28/20261.49 USD
4/27/20261.50 USD
4/24/20261.51 USD
4/23/20261.57 USD
4/22/20261.65 USD
4/21/20261.72 USD
4/20/20261.50 USD
4/17/20261.50 USD
4/16/20261.44 USD
4/15/20261.50 USD
4/14/20261.38 USD
4/13/20261.37 USD
4/10/20261.34 USD
4/9/20261.40 USD
4/8/20261.36 USD
4/7/20261.32 USD
4/6/20261.41 USD
4/2/20261.44 USD
4/1/20261.42 USD
3/31/20261.45 USD
3/30/20261.30 USD
3/27/20261.39 USD
3/26/20261.61 USD
3/25/20261.81 USD
3/24/20261.82 USD
3/23/20261.77 USD
3/20/20261.80 USD
3/19/20262.00 USD
3/18/20261.83 USD
3/17/20261.70 USD
3/16/20261.71 USD
3/13/20261.80 USD
3/12/20261.94 USD
3/11/20261.98 USD
3/10/20261.90 USD
3/9/20262.03 USD
3/6/20261.86 USD
3/5/20261.68 USD
3/4/20261.62 USD
3/3/20261.42 USD
3/2/20261.38 USD
2/27/20261.41 USD
2/26/20261.35 USD
2/25/20261.22 USD
2/24/20261.20 USD
2/23/20261.18 USD
2/20/20261.19 USD
2/19/20261.07 USD
2/18/20261.10 USD
2/17/20261.08 USD
2/13/20261.09 USD
2/12/20261.08 USD
2/11/20261.08 USD
2/10/20261.12 USD
2/9/20261.13 USD
2/6/20261.05 USD
2/5/20261.00 USD
2/4/20261.06 USD
2/3/20261.10 USD
2/2/20261.12 USD
1/30/20261.16 USD
1/29/20261.19 USD
1/28/20261.21 USD
1/27/20261.25 USD
1/26/20261.31 USD
1/23/20261.45 USD
1/22/20261.48 USD
1/21/20261.45 USD
1/20/20261.39 USD
1/16/20261.43 USD
1/15/20261.40 USD
1/14/20261.43 USD
1/13/20261.48 USD
1/12/20261.61 USD
1/9/20261.65 USD
1/8/20261.60 USD
1/7/20261.67 USD
1/6/20261.57 USD
1/5/20261.69 USD
1/2/20261.75 USD
12/31/20251.59 USD
12/30/20251.70 USD
12/29/20251.85 USD
12/26/20251.53 USD
12/24/20251.52 USD
12/23/20251.46 USD
12/22/20251.45 USD
12/19/20251.36 USD
12/18/20251.36 USD
12/17/20251.33 USD
12/16/20251.40 USD
12/15/20251.22 USD
12/12/20251.06 USD
12/11/20251.06 USD
12/10/20251.11 USD
12/9/20251.08 USD
12/8/20251.06 USD
12/5/20251.14 USD
12/4/20251.27 USD
12/3/20251.29 USD
12/2/20251.32 USD
12/1/20251.63 USD
11/28/20251.52 USD
11/26/20251.48 USD
11/25/20251.44 USD
11/24/20251.45 USD
11/21/20251.39 USD
11/20/20251.25 USD
11/19/20251.38 USD
11/18/20251.38 USD
11/17/20251.47 USD
11/14/20251.60 USD
11/13/20251.57 USD
11/12/20251.83 USD
11/11/20252.15 USD
11/10/20252.92 USD
11/7/20252.91 USD
11/6/20252.80 USD
11/5/20252.85 USD
11/4/20252.94 USD
11/3/20252.70 USD
10/31/20252.65 USD
10/30/20252.61 USD
10/29/20252.78 USD
10/28/20252.85 USD
10/27/20252.73 USD
10/24/20252.94 USD
10/23/20253.00 USD
10/22/20252.72 USD
10/21/20253.00 USD
10/20/20253.17 USD
10/17/20253.02 USD
10/16/20253.43 USD
10/15/20253.31 USD
10/14/20253.50 USD
10/13/20253.35 USD
10/10/20253.42 USD
10/9/20253.44 USD
10/8/20253.49 USD
10/7/20253.55 USD
10/6/20253.77 USD
10/3/20253.37 USD
10/2/20253.51 USD
10/1/20253.27 USD
9/30/20253.21 USD
9/29/20253.52 USD
9/26/20253.33 USD
9/25/20253.29 USD
9/24/20253.44 USD
9/23/20253.39 USD
9/22/20253.47 USD
9/19/20253.59 USD
9/18/20253.53 USD
9/17/20252.88 USD
9/16/20252.93 USD
9/15/20252.61 USD
9/12/20252.64 USD
9/11/20252.79 USD
9/10/20252.67 USD
9/9/20252.83 USD
9/8/20252.71 USD
9/5/20252.73 USD
9/4/20252.81 USD
9/3/20252.79 USD
9/2/20252.88 USD
8/29/20252.75 USD
8/28/20252.80 USD
8/27/20252.77 USD
8/26/20253.05 USD
8/25/20253.24 USD
8/22/20253.45 USD
8/21/20253.42 USD
8/20/20253.21 USD
8/19/20253.21 USD
8/18/20253.30 USD
8/15/20253.52 USD
8/14/20253.24 USD
8/13/20252.97 USD
8/12/20253.28 USD
8/11/20252.66 USD
8/8/20252.48 USD
8/7/20252.31 USD
8/6/20252.18 USD
8/5/20252.19 USD
8/4/20252.49 USD
8/1/20252.00 USD
7/31/20252.07 USD
7/30/20251.66 USD
7/29/20251.65 USD
7/28/20251.64 USD
7/25/20251.84 USD
7/24/20251.94 USD
7/23/20251.81 USD
7/22/20251.69 USD
7/21/20251.35 USD
7/18/20251.16 USD
7/17/20251.20 USD
7/16/20251.10 USD
7/15/20251.09 USD
7/14/20251.05 USD
Access this data via the Eulerpool API
Get Free API Key

Health In Tech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
5.77 M USD
205,600.00 USD
79,700.00 USD
Jan 1, 2023
19.15 M USD
3.38 M USD
2.48 M USD
Jan 1, 2024
19.49 M USD
989,900.00 USD
670,500.00 USD
Jan 1, 2025 (e)
32.70 M USD
982,730.00 USD
862,186.50 USD
Jan 1, 2026 (e)
42.46 M USD
1.42 M USD
-287,395.48 USD
Jan 1, 2027 (e)
80.91 M USD
12.26 M USD
10.92 M USD

Health In Tech Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 12, 2026, 2:29 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
NET INCOMEM USD
SHARESM
2022202320242025e2026e2027e
5.0019.0019.0032.0042.0080.00
–280.00–68.4231.2590.48
100.0084.2178.9578.9578.9578.95
5.0016.0015.0025.2633.1663.16
–2.00–––10.00
54.0754.0753.6653.6653.6653.66
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Health In Tech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Health In Tech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Health In Tech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Health In Tech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Health In Tech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Health In Tech stock margins

The Health In Tech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Health In Tech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Health In Tech.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
94.21 %
3.56 %
1.38 %
Jan 1, 2023
87.97 %
17.66 %
12.93 %
Jan 1, 2024
79.21 %
5.08 %
3.44 %
Jan 1, 2025 (e)
79.21 %
3.01 %
2.64 %
Jan 1, 2026 (e)
79.21 %
3.34 %
-0.68 %
Jan 1, 2027 (e)
79.21 %
15.16 %
13.50 %

Health In Tech Stock Revenue, EBIT, Earnings per Share

The Health In Tech earnings per share therefore indicates how much revenue Health In Tech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2022
0.11 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.35 USD
0.06 USD
0.05 USD
Jan 1, 2024
0.36 USD
0.02 USD
0.01 USD
Jan 1, 2025 (e)
0.57 USD
0.02 USD
0.02 USD
Jan 1, 2026 (e)
0.75 USD
0.03 USD
-0.01 USD
Jan 1, 2027 (e)
1.42 USD
0.23 USD
0.19 USD

Health In Tech business model & stock analysis

Health In Tech Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Health In Tech historical P/E ratio, EBIT multiple, and P/S ratio

Health In Tech annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Health In Tech shares outstanding

The number of shares of Health In Tech was 53.66 M in 2025. This indicates how many shares Health In Tech is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
54.07 M Stocks
Jan 1, 2023
54.07 M Stocks
Jan 1, 2024
53.66 M Stocks
Jan 1, 2025 (e)
53.66 M Stocks
Jan 1, 2026 (e)
53.66 M Stocks
Jan 1, 2027 (e)
53.66 M Stocks

Current Health In Tech forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy80.00 % (4)
Hold20.00 % (1)
Sell0.00 % (0)
12M Price Target
4.59
Last Price
1.06
Currency
USD
12M Return Potential
333.02 %
LTM Return
0 %

Health In Tech Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
7/27/2026-0.02USD7.62 MUSD2026 Q2
5/13/2026-0.03USD7.42 MUSD2026 Q1
5/8/2026-0.03USD7.42 MUSD2026 Q1
4/20/2026-0.03USD7.41 MUSD2026 Q1
3/25/2026-0.01USD7.35 MUSD2025 Q4
3/23/2026-0.01USD7.35 MUSD2025 Q4

Health In Tech shareholder structure

% Name
39.62351%
Johnson (Tim Donald)
Johnson (Tim Donald)
14.28318%
Qian (LinLin)
Qian (LinLin)
0.22575%
Umemezia (Chike)
Umemezia (Chike)
0.22276%
UBS Financial Services, Inc.
UBS Financial Services, Inc.
0.18802%
Yousuf (Imran Mohammed)
Yousuf (Imran Mohammed)
0.18634%
Hayes (Timothy)
Hayes (Timothy)

Health In Tech Executives and Management Board

JL

Mr. Jonathan Lockett

(64)

Chief Strategy Officer

Compensation557,614.00 USD
IY

Mr. Imran Yousuf

(32)

Chief Technology Officer

Compensation491,398.00 USD
TJ

Mr. Tim Johnson

(59)

Chief Executive Officer, Founder, Director · since 2014

Compensation466,500.00 USD
JQ

Ms. Julia Qian

(50)

Chief Financial Officer, Director · since 2022

Compensation407,500.00 USD
JG

Ms. Jennifer Guerrica

(48)

Chief Information Security Officer

Frequently asked questions about Health In Tech

Analysts currently set an average price target of 4.59 USD for the Health In Tech stock (median: 4.59 USD), implying +333.0 % versus the latest price. The consensus is based on 5 analyst ratings.

Health In Tech Analyst Price Targets 2026

All fundamentals and in-depth analysis of Health In Tech

Our stock analysis for Health In Tech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health In Tech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Health In Tech Stock
Health In Tech Revenue→
Health In Tech Stock
Health In Tech Net Income→
Health In Tech Stock
Health In Tech P/E→
Health In Tech Stock
Health In Tech P/S→
Health In Tech Stock
Health In Tech EBIT→
Health In Tech Stock
Health In Tech Dividend→
Health In Tech Stock
Health In Tech Directors Dealings→
Health In Tech Stock
Health In Tech Stocks→
Health In Tech Stock
Health In Tech Market capitalization→
Health In Tech Stock
Health In Tech Debt→
Health In Tech Stock
Health In Tech Liabilities→
Health In Tech Stock
Health In Tech Equity→
Health In Tech Stock
Health In Tech AAQS→
Health In Tech Stock
Health In Tech Employees→
Health In Tech Stock
Health In Tech ROE→
Health In Tech Stock
Health In Tech ROA→
Health In Tech Stock
Health In Tech ROCE→
Health In Tech Stock
Health In Tech News→
Health In Tech Stock
Health In Tech Analyst Price Targets→

Finance Stocks

Heartland Group HoldingsHDFC Life Insurance CompanyHecto Financial CoHDFC Bank Limited ADRHeidelberger BeteiligungsholdingHDFC BankHelia GroupHDFC Asset Management CompanyHeliadHDB Financial ServicesHelios Fairfax PartnersHci GroupAll Stocks A–Z →